Hofseth BioCare ASA: Mandatory Notification of Trade

Reference is made to the stock exchange announcement by Hofseth Biocare ASA ("HBC" or the "Company") on 27 October 2025 regarding completion of a private placement (the "Private Placement") of new shares in the Company.

In the Private Placement, Hofseth International AS was allocated 28,666,666 new shares at the subscription price of NOK 1.80.

Please refer to the attached notification form for further information.

This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19.

For further information, please contact:

Jon Olav Ødegård, CEO at HBC
Phone: +47 936 32 966
E-mail: [email protected]

Attachment

• PDMR notification form Hofseth International AS

You May Also Be Interested In

• Atlassian Names Carahsoft Gliffy Partner of the Year and Deviniti Customer Value Expansion Partner of the Year
• KFC Canada and Cheetos Flamin’ Hot are serving heat from menu to merch
• VILVI Group unaudited consolidated financial results for the six months of 2026